Average cost of developing a new drug could be up to $1.5 billion less than pharmaceutical industry claims

The costs of bringing a new drug to market may be lower than has been previously claimed by the pharmaceutical industry, according to a study published today (Tuesday March 3, 2020) in the journal JAMA. Researchers from the UK and Belgium used publicly available data to estimate how much, on average, drug companies spend on research and development to bring a new medicine to market.
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.